Search

everythinglearnresearchcommunity

for

Search:↓

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

No definitive link between finasteride and male breast cancer, but further research is needed.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Tamoxifen caused hair loss in a 52-year-old woman.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Minoxidil in breast milk may harm nursing infants.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.